Condition: Venous Thromboembolism (VTE) · Sponsor: Regeneron Pharmaceuticals
This study is researching an experimental drug called REGN7508 (called "study drug"). The study is focused on adults undergoing elective, unilateral (one side) total knee replacement surgery. The aim of the study is to see how effective the study drug is at preventing Venous Thromboembolism (VTE) and other related diseases after total knee replacement surgery. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is in the blood at different times * Whether the body makes antibodies against the study drug (which could make the study drug less effective or could lead to side effects)
This description comes directly from the study's public registry record.
Clinical Trials Administrator · 844-734-6643 · clinicaltrials@regeneron.com
Always discuss trial participation with your own doctor first.
| Shoals Medical Trials, Inc. | Sheffield, Alabama, United States | Recruiting |
| CARI Clinical Trials | Riverside, California, United States | Recruiting |
| Denver Metro Orthopedics, P.C. Englewood Location | Englewood, Colorado, United States | Recruiting |
| Delray Physician Care Center | Delray Beach, Florida, United States | Recruiting |
| Bioresearch Partner | Miami, Florida, United States | Recruiting |
| Sacred Heart Health System Inc | Pensacola, Florida, United States | Recruiting |
| Gulfcoast Research Institute | Sarasota, Florida, United States | Recruiting |
| Phoenix Clinical Research | Tamarac, Florida, United States | Recruiting |
| Sinai Hospital of Baltimore, Inc. | Baltimore, Maryland, United States | Recruiting |
| Brigham and Women's Hospital | Boston, Massachusetts, United States | Recruiting |
| Curalta Clinical Trials | Westwood, New Jersey, United States | Recruiting |
| Duke University Health System (Duke Health), Duke University Hospital | Durham, North Carolina, United States | Recruiting |
+ 34 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07015905